DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

2.88 -0.12 (-4.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RIGL $2.88 -4.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.93
Previous Close $3.00
Daily Range $2.86 - $2.98
52-Week Range $1.56 - $5.20
Market Cap $254.9M
P/E Ratio -3.49
Dividend (Yield) $0.00 (0.0%)
Volume 506,154
Average Daily Volume 442,302
Current FY EPS -$0.71

Sector

Healthcare

Industry

Drug Makers

Rigel Pharmaceuticals, Inc. (RIGL) Description

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Website: http://www.rigel.com/

News & Commentary Rss Feed

Why Rigel Pharmaceuticals Shares Surged Higher Today

Wall Street analysts offer up a buy rating and a lofty price target on Rigel Pharmaceuticals.

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

Rigel Pharmaceutical's (RIGL) CEO Raul Rodriguez on Q2 2015 Results - Earnings Call Transcript.

Rigel Pharmaceuticals (RIGL) Q2 2015 Results - Earnings Call Webcast

Bristol-Myers Announces Job Cuts, Changes in R&D Sites - Analyst Blog

Dry Eye Development Reaches The Eleventh Hour

Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today

Rigel Pharmaceuticals (RIGL) Q1 2015 Results - Earnings Call Webcast

Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape

Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Pre

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Press Releases

3 Momentum Picks Under $10 to Sail the Turbulent Market - Analyst Blog

See More RIGL News...

RIGL's Top Competitors

RIGL $2.88 (-4.00%)
Current stock: RIGL
AMGN $147.46 (-2.85%)
Current stock: AMGN
GILD $101.49 (-3.41%)
Current stock: GILD
BIIB $292.50 (-1.61%)
Current stock: BIIB